CRSP   $46.93  -1.59% Market Closed After Close 47.5533 1.33%

CRISPR Therapeutics AG
Total Cash 2.00B
totalCashPerShare 23.502
EBITDA -335.17M
Total Debt 231.30M
quickRatio 15.659
currentRatio 15.728
Total Revenue 202.23M
debtToEquity 11.676
Revenue/Share 2.483
ROA -0.097720005
ROE -0.14001
grossProfits
freeCashflow -51.44M
operatingCashflow -121.76M
earningsGrowth
revenueGrowth -0.993
grossMargins -1.39681
ebitdaMargins -1.65741
operatingMargins -292.57254
profitMargins -1.31438
enterpriseValue 2.54B
forwardPE -10.610878
floatShares 83.77M
sharesOutstanding 85.35M
sharesShort 17.59M
sharesShortPriorMonth 17.54M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.80%
Short Ratio help_outline 16.52%
shortPercentOfFloat 0.23%
impliedSharesOutstanding
bookValue 23.522
Price To Book help_outline 2.16
earningsQuarterlyGrowth
netIncomeToCommon -265.80M
trailingEps -2.79%
forwardEps -4.78%
enterpriseToEbitda -7.57
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.28 4Q 2024
institutionsCount 579
lastUpdated Nov. 7, 2024, 2:32 a.m.